f1a1c1eeb6a9f9e624b4ade32493426b75a5bbf79d1d8a047d771865b1ef1348

Product Revenue

- Recurring

- Non-Recurring

Service Revenue

Non-Commercial Revenue

Total Revenue

534534eb6b549986be11c578d894df278cee05ad478dbbf942d06dfee651fa16

Current Assets (USD, thousands)

Cash and Cash Equivalents (USD, thousands)

Accounts Receivable (USD, thousands)

Inventory (USD, thousands)

Non-Current Assets (USD, thousands)

Property, Plant, and Equipment (PP&E) (USD, thousands)

Goodwill (USD, thousands)

Intangible Assets (USD, thousands)

Current Liabilities (USD, thousands)

Accounts Payable (USD, thousands)

Short-term Debt (USD, thousands)

Accrued Expenses (USD, thousands)

Non-Current Liabilities (USD, thousands)

Long-term Debt (USD, thousands)

Lease Liabilities (USD, thousands)

Deferred Tax Liabilities (USD, thousands)

Shareholders' Equity (USD, thousands)

Retained Earnings (USD, thousands)

Common Stock (USD, thousands)

Additional Paid-in Capital (USD, thousands)

6afc19b948fedf7e06aba7d1b2729bb7d0f22d7fc362cab2a565518856dbd13d

Adjustments for Non-Cash Items (USD, thousands)

Stock-Based Compensation (USD, thousands)

Changes in Working Capital (USD, thousands)

Capital Expenditures (CapEx) (USD, thousands)

Proceeds from / Repayments of Debt (USD, thousands)

Share Repurchases (USD, thousands)

Dividend Payments (USD, thousands)

Net Change in Cash (USD, thousands)

134db5276186195199006e68465bc6e25fc0587b346e201b0085bb670f1e5aee

Total Revenue (USD, actual)

Cost of Goods Sold (COGS) (USD, actual)

Selling, General, and Administrative Expenses (SG&A) (USD, actual)

Research and Development (R&D) (USD, actual)

Depreciation and Amortization (D&A) (USD, actual)

Interest Expense (USD, actual)

Operating Income (EBIT) (USD, actual)

Net Income (USD, actual)

Earnings Per Share (EPS) - Basic (USD, actual)

Earnings Per Share (EPS) - Diluted (USD, actual)

31cd9652089759caf30d684514184142da5b7a3f47abb2e32469887ee3306c9e

United States

Switzerland

Germany

Japan

All Other Countries

d2655e027a6441b20f42d77c25e456d6019d80aad8afe594036d9f95e1ff9233

Product revenue (USD, thousands)

Service revenue (USD, thousands)

Total revenue (USD, thousands)

Cost of product revenue (USD, thousands)

Cost of service revenue (USD, thousands)

Research and development (USD, thousands)

Sales and marketing (USD, thousands)

General and administrative (USD, thousands)

Total costs and operating expenses (USD, thousands)

Loss from operations (USD, thousands)

Interest income, net (USD, thousands)

Other expense, net (USD, thousands)

Total other income, net (USD, thousands)

Loss before income taxes (USD, thousands)

Income tax expense (USD, thousands)

Net loss (USD, thousands)

Net loss per share — basic and diluted (USD)

Weighted average common shares outstanding — basic and diluted

6facfd7f7aede38b6276d3230704fcc8c7acc79055e4708096f05fa7da9858c9

Cash and cash equivalents (USD, thousands)

Short-term investments (USD, thousands)

Accounts receivable (USD, thousands)

Prepaid expenses and other current assets (USD, thousands)

Total current assets (USD, thousands)

Property and equipment, net (USD, thousands)

Right-of-use assets, net (USD, thousands)

Other long-term assets (USD, thousands)

Restricted cash (USD, thousands)

Total assets (USD, thousands)

Accounts payable (USD, thousands)

Accrued expenses and other current liabilities (USD, thousands)

Deferred revenue (USD, thousands)

Lease liabilities, short-term (USD, thousands)

Total current liabilities (USD, thousands)

Lease liabilities, long-term (USD, thousands)

Other long-term liabilities (USD, thousands)

Total liabilities (USD, thousands)

Total stockholders’ equity (USD, thousands)

Total liabilities and stockholders’ equity (USD, thousands)

d93d47de159e48d10333709c58d0d736a42fa1461ddb4fca8f543c1724d1804e

Rapid Micro Biosystems Inc (RPID)

Financials